171 related articles for article (PubMed ID: 17360856)
1. Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.
Peterson SH; Nardelli DT; Warner TF; Callister SM; Torrealba JR; Schell RF
Clin Vaccine Immunol; 2007 May; 14(5):510-7. PubMed ID: 17360856
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.
Nardelli DT; Warner TF; Callister SM; Schell RF
Clin Vaccine Immunol; 2006 Aug; 13(8):884-91. PubMed ID: 16893988
[TBL] [Abstract][Full Text] [Related]
3. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.
Nardelli DT; Burchill MA; England DM; Torrealba J; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1075-84. PubMed ID: 15539509
[TBL] [Abstract][Full Text] [Related]
4. Role of IL-17, transforming growth factor-beta, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice.
Nardelli DT; Kevin Luk KH; Kotloski NJ; Warner TF; Torrealba JR; Callister SM; Schell RF
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):265-74. PubMed ID: 18522647
[TBL] [Abstract][Full Text] [Related]
5. CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection.
Nardelli DT; Cloute JP; Luk KH; Torrealba J; Warner TF; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2005 Jun; 12(6):786-92. PubMed ID: 15939755
[TBL] [Abstract][Full Text] [Related]
6. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD; Jobe DA; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
[TBL] [Abstract][Full Text] [Related]
7. Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice.
Nardelli DT; Luedtke JO; Munson EL; Warner TF; Callister SM; Schell RF
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):78-89. PubMed ID: 20662925
[TBL] [Abstract][Full Text] [Related]
8. The MHC class I-related FcRn ameliorates murine Lyme arthritis.
Crowley H; Alroy J; Sproule TJ; Roopenian D; Huber BT
Int Immunol; 2006 Mar; 18(3):409-14. PubMed ID: 16415101
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.
Lim LC; England DM; Glowacki NJ; DuChateau BK; Schell RF
Infect Immun; 1995 Dec; 63(12):4818-25. PubMed ID: 7591141
[TBL] [Abstract][Full Text] [Related]
10. Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis.
Codolo G; Amedei A; Steere AC; Papinutto E; Cappon A; Polenghi A; Benagiano M; Paccani SR; Sambri V; Del Prete G; Baldari CT; Zanotti G; Montecucco C; D'Elios MM; de Bernard M
Arthritis Rheum; 2008 Nov; 58(11):3609-17. PubMed ID: 18975343
[TBL] [Abstract][Full Text] [Related]
11. IgE anti-Borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with Lyme disease.
Bluth MH; Robin J; Ruditsky M; Norowitz KB; Chice S; Pytlak E; Nowakowski M; Durkin HG; Smith-Norowitz TA
Scand J Immunol; 2007 Apr; 65(4):376-82. PubMed ID: 17386029
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.
Munson EL; DeCoster DJ; Nardelli DT; England DM; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2004 Jan; 11(1):35-41. PubMed ID: 14715542
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species.
Kotloski NJ; Nardelli DT; Peterson SH; Torrealba JR; Warner TF; Callister SM; Schell RF
Clin Vaccine Immunol; 2008 Aug; 15(8):1199-207. PubMed ID: 18579699
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.
Kuo J; Nardelli DT; Warner TF; Callister SM; Schell RF
Clin Vaccine Immunol; 2011 Jul; 18(7):1125-32. PubMed ID: 21613457
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
[TBL] [Abstract][Full Text] [Related]
16. [Immunopathology of Lyme arthritis].
Pancewicz SA; Rutkowski R; Rutkowski K; Zajkowska JM; Kondrusik M
Pol Merkur Lekarski; 2007 Aug; 23(134):141-4. PubMed ID: 18044347
[TBL] [Abstract][Full Text] [Related]
17. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.
Schaible UE; Gay S; Museteanu C; Kramer MD; Zimmer G; Eichmann K; Museteanu U; Simon MM
Am J Pathol; 1990 Oct; 137(4):811-20. PubMed ID: 2221014
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis.
Kannian P; McHugh G; Johnson BJ; Bacon RM; Glickstein LJ; Steere AC
Arthritis Rheum; 2007 Dec; 56(12):4216-25. PubMed ID: 18050219
[TBL] [Abstract][Full Text] [Related]
19. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.
Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM
Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729
[TBL] [Abstract][Full Text] [Related]
20. Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice.
Amlong CA; Nardelli DT; Peterson SH; Warner TF; Callister SM; Schell RF
Clin Vaccine Immunol; 2006 Feb; 13(2):289-96. PubMed ID: 16467340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
